Claritin Tablet, Orally Disintegrating
FDA Label NDC 11523-7157

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Bayer Healthcare Llc. for the product Claritin (NDC 11523-7157). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding other, active ingredient (in each tablet), purpose, uses, otc - do not use, otc - ask doctor, otc - when using, otc - stop use, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Other

Drug Facts

Active Ingredient (In Each Tablet)

Loratadine 10 mg

Purpose

Antihistamine

Uses

temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

  • runny nose
  • itchy, watery eyes
  • sneezing
  • itching of the nose or throat

Otc - Do Not Use

Do not use if you have ever had an allergic reaction to this product or any of its ingredients.

Otc - Ask Doctor

Ask a doctor before use if you have liver or kidney disease. Your doctor should determine if you need a different dose.

Otc - When Using

When using this product do not take more than directed. Taking more than directed may cause drowsiness.

Otc - Stop Use

Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away.

Otc - Pregnancy Or Breast Feeding

If pregnant or breast-feeding, ask a health professional before use.

Otc - Keep Out Of Reach Of Children

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

  • place 1 tablet on tongue; tablet disintegrates, with or without water
  • adults and children 6 years and over1 tablet daily; not more than 1 tablet in 24 hours
    children under 6 years of ageask a doctor
    consumers with liver or kidney diseaseask a doctor

Other Information

  • safety sealed: do not use if the individual blister unit imprinted with Claritin® RediTabs® is open or torn
  • store between 20° to 25°C (68° to 77°F)
  • use tablet immediately after opening individual blister
  • complies with USP Procedure 2 for Assay and Organic Impurities and Test 2 for Disintegration

Inactive Ingredients

anhydrous citric acid, gelatin, mannitol, mint flavor

Questions Or Comments?

1-800-CLARITIN (1-800-252-7484) or www.claritin.com

Principal Display Panel - 10 Tablet Carton

Original Prescription Strength
NDC 11523-7157-2

Non-Drowsy*
Claritin
®
RediTabs®
loratadine 10 mg/antihistamine

Indoor & Outdoor
Allergies

*When taken as directed. See Drug Facts Panel.

24
Hour

Relief of:

  • Sneezing
  • Runny Nose
  • Itchy, Watery Eyes
  • Itchy Throat
    or Nose
  • No Water Needed
    Melts in Your Mouth

    10
    ORALLY
    DISINTEGRATING TABLETS

    Principal Display Panel (10 Tablet Carton)

    Principal Display Panel (10 Tablet Carton)

Principal Display Panel - 60 Tablet Twin Pack Carton

TWIN PACK

Two 30ct Cartons
60 RediTabs
®

Original Prescription Strength

NDC 11523-4329-1

Non-Drowsy*
Claritin
®
RediTabs®
loratadine 10 mg/antihistamine

Indoor & Outdoor
Allergies

*When taken as directed. See Drug Facts Panel.

24
Hour

Relief of:

  • Sneezing
  • Runny Nose
  • Itchy, Watery Eyes
  • Itchy Throat
    or Nose
  • No Water Needed
    Melts in Your Mouth

    60
    ORALLY
    DISINTEGRATING TABLETS

    Principal Display Panel (60 Tablet Twin Pack Carton)

    Principal Display Panel (60 Tablet Twin Pack Carton)

* Please review the disclaimer below.